跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
WELIREG
Authorized
STANDARD
WELIREG
Merck Canada Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
aec72be5864740fd
Company
Merck Canada Inc
Type
Standard
Approval Details
Approval Id
aec72be5864740fd
Drug Approval Canada Name
WELIREG
Product Name
WELIREG
Status
Marketed
Status Date
2022-09-01
Original Market Date
2022-09-01
Din
02528908
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L01XX74 BELZUTIFAN
Atc Name
l 01 xx 74
Aig Number
0163901001
Company Name
Merck Canada Inc
Company Address
16750 Route Transcanadienne, Kirkland, Quebec, Canada, H9H 4M7
Active Ingredients
BELZUTIFAN
40 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
aec72be5864740fd
Type
Standard
Back to Health Canada Approvals
WELIREG - Health Canada Drug Approval Details